SAN FRANCISCO, CA, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Artificial intelligence has firmly established ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback